___

• Umakanth A, Khatwa and P.S.N. Menon. Management
• of Undescended Testis. Ýndian J Pediatr 2000; 67 (6): 449.
• Rajfer J. Surgical and hormonal therapy for cryptorchidism: An Overview. Horm Res 1998; 30: 139.
• Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR. Prevalance and natural history of cryptorchidism. Pediatrics 1993; 92: 44.
• Hjertkvist M, Dauber JE, Bergh A. Cryptorchidism: A registry-based study in Sweden on some factors of some possible etiological importance. J Epidemiol Community Health 1989; 146: 324.
• Y. Kubota, S. Nef, P. Farmer, C. Temelcos, L. Parada, J. Hutson. Leydig insulin-like hormone, gubernacular development and testicular descent. J Urol 2001; 165: 1673.
• Gill B. Kogan S. Crytorchidism: Current consept. Pediatr Clin North Am 1997; 44: 1211.
• Elder JS. The Undescended Testis: Hormonal and surgical management. Surg Clin North Am 1988; 68: 983.
• Miller OF, Stock JA, Cilento BG, McAleer IM, Kaplan GW.Prospective evaluation of human chorionic gonadotropin in the differentiation of undescended testes from retractile testes. J Urol 2003; 169: 2328.
• Bukowski TP, Sedberry S and Richardson B. Is human chorionic gonadotropin useful for identifying and treating nonpalpable testis? J Urol 2001; 165: 221.
• MacKinnon AE. The undescended testis. Indian J Pediatr 2005; 72: 429.
• Kapur DK, Ahuja GK. Immunocytochemistry of male reproductive organs. Arch Androl 1989; 23(3): 169.
• Leung WY, Poon M, Fan TW, Siu KW, Chung KW, Kwok WK, Kwok CH. Testicular volume of boys after inguinal herniotomy: combined clinical and radiological follow-up. Pediatr Surg Int 1999; 15(1): 40-1.
• Canavese F, Cortese MG, Magro P, Lonati L, Teruzzi E, de Sanctis C, et al. Cryptorchidism: medical and surgical treatment in the 1st year of life. Pediatr Surg Int 1998; 14: 2.
• Lala R, Matarazzo P, Chiabotto P, Gennari F, Cortese MG, Canavese F, et al. Early hormonal and surgical treatment of cryptorchidism. J Urol 1997; 157: 1898.
• Grasso M, Buonaguidi A, Lania C, Bergamaschi F, Castelli M, Rigatti P. Postpubertal cryptorchidism: Review and evaluation of the fertility. Eur Urol 1991; 20: 126.
• Mininberg DT, Rodger JC, Bedford JM. Ultrastructural evidence of the onset of testicular pathological conditions in the cryptorchid human testis ithin the first year of life. J Urol 1982; 128: 782.
• Hadziselimoviç, F: Hormonal treatment In: Hadziselimoviç MD (Ed): Cryptorchidism: Management and Implications. Berlin: Springer Verlag 1983; 101-14.
• Rajfer J, Handelsman DJ, Swerdloff RS, Hurwitz R, Kaplan H, Vandergast T. Hormonal therapy of cryptorchidism: a randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone N Engl J Med 1986; 314: 466.19
• Ünal D, Yeni E, Verit A, Çiftçi H. Ýnmemiþ testiste primer human koriyonik gonadotropin tedavisine yanýtý etkileyen faktörler. Türk Üroloji Dergisi 2002; 28(2): 166
• Fedder J, Boesen M: Effect of a combined GnRH/hCG therapy in boys with ndescended testicles: Evaluated in relation to testicular localization within the first week after birth. Arch Androl 1998; 40: 181.
• Garagorri JM, Job JC, Canlorbe P. Results in early treatment of cryptorchidism with human chorionic gonadotropin. J Pediatr. 1982; 101: 923.
• Job JC, Canlorbe P, Garagorri JM, Toublanc JE. Hormonal therapy of cryptorchidism with human chorionic gonadotropin (hCG) Urol Clin N Amer 1982; 9: 405.
• Cortes D, Thorup J, Visfeldt J, Hormonal treatment may harm the germ cells in 1 to 3- year-old boys with cryptorchdism. J Urol 2000; 162: 1290.
• Heýskanen P, Býllýg H, Topparý J, Kaleva M, Arsalo A, Rapola J, et al. Appoptotic cell death in the normal and cryptorchid human testis: the effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res 1996; 40: 351.
• Christiansen P, Müller J, Buhl S, Hansen OR, Hobolth N, Jacobsen BB,et al. Hormonal treatment of cryptorchidism-hCG or GnRH- a multicentre study. Acta Pediatr 1992; 81: 605.
• Giannopoulos MF, Vlachakis IG, Charissis GC. 13 years’ experience with the combined hormonal therapy of cryptorchidism. Horm Res 2001; 55: 33.
• Walsh PC, Curry N, Mills RC, Siiteri PK. Plasma androjen response to hCH stimulation in prepubertal boys with hypospadias and cryptorchidism. J Clin Endocrinol Metab 1976; 42: 52.
• Cacciari E, Gicognani A, Prazzoli P, Zappola F, Tassoni P, Bernardi F, et al. Hypophysogonadal function in the cryptorchid child: differences between unilateral and bilateral cryptorchids. Acta Endocrinol 1976; 83: 182.
• Gendrel D, Roger M, Job JC. Plasma gonadotropin and testosterone values in infants with cryptorchidism. J Pediatr 1980; 97: 217.
• Muinck K, Hazebroek FWJ, Drop SLS, Degenhart HJ, Molenaar JC, Visser HKA.
• Hormonal evaluation of boys with undescended testes during their first year of life. J Clin Endocrinol Metab 1988; 66: 159.
• Urry RL, Carrell DT, Star NT, Snow BW and Middleton RG. The incidence of antisperm antibodies in infertility patients with a history of cryptorchidism. J Urol 1994; 151: 381.
• Lenzi A, Gandini L, Lombardo F, Cappa M, Nardini P, Ferro F, Borrelli P, and Dondero F. Antisperm antibodies in young boys. Andrologia 1991; 23: 233.
• Sinisi AA, Pasquali D, Papparella A, Valente A, Orio F, Esposito D, et al. Antisperm antibodies in cryptorchidism before and after surgery. 1998; 160:1834.